Posters Presentation

Please prepare your poster in accordance with the size of display: 90 cm x 105 cm. Your poster should not exceed these measurements.

Velcro / pins will be available.

Tuesday 27 Wednesday 28 Thursday 29
Poster
Tittle
Authors
P29 TEMPORAL RELATIONSHIP OF HUMAN PARECHOVIRUS 1 INFECTIONS WITH OTITIS MEDIA IN YOUNG CHILDREN S. Tauriainen, S. Oikarinen, K. Taimen, J. Laranne, M. Sipilä, M. Lönnrot, J. Ilonen, O. Simell, M. Knip and H. Hyöty.
P30 DETECTION OF ENTEROVIRUSES IN THE INTESTINE OF TYPE 1 DIABETIC PATIENTS S. Oikarinen, S. Tauriainen, T. Homkanen, M. Oikarinen, K. Vuori, K. Kaukinen, I. Rantala, M. Mäki and H. Hyöty.
P31 THE PATHOGENESIS OF ENTEROVIRUS 94 Teemu Smura, Petri Ylipaasto and Merja Roivainen.
P32 ENTEROVIRUS STRAIN ISOLATED FROM DIABETIC CHILD BELONGS TO A GENETIC SUBCLUSTER OF ECHOVIRUS 11 BUT IS ALSO NEUTRALIZED WITH MONOTYPIC ANTISERA TO COXSACKIEVIRUS A9 Haider Al-Hello, Anja Paananen, Mervi Eskelinen, Petri Ylipaasto, Tapani Hovi, O.Korsgren, Alexander N. Lukashev, Shubhada Bobegamage and Merja Roivainen.
P33 TROPISM OF DIFFERENT VIRUS STRAINS, INCLUDING COXSACKIEVIRUS, IN HUMAN PANCREATIC EXOCRINE CELLS M.Hodik, G.Frisk and O.Korsgren.
P34 SITE SPECIFIC GENOME CHARACTERISATION OF A DISSEMINATED HUMAN ENTEROVIRUS 71 INFECTION Caroline Tapparel,, Daniel Gerlach,, Sandra van Belle,, Delphine Garcia, Lara Turin,, Samuel Cordey,, Alain Nguyen, Evgeny Zdobnov,, and Laurent Kaiser,.
P35 ENZYMATIC BIOSENSORS CAN DISCRIMINATE BETWEEN FOOT-AND-MOUTH DISEASE VIRUS INFECTED AND VACCINATED ANIMALS M.T. Sánchez, R.M. Ferraz, L. Delgui, E. Blanco, A. Villaverde, M.F. Rosas and F. Sobrino.
P36 INSIGHTS INTO THE MECHANISM OF LETHAL MUTAGENESIS: REPLICATIVE INTERFERENCE BY MULTIPLE POINT MUTANTS Celia Perales, Roberto Mateo, Rubén Agudo, Mauricio G. Mateu and Esteban Domingo.
P37 DEVELOPMENT OF TRANSGENIC MOUSE TEST FOR EVALUATION OF IMMUNOGENICITY AND PROTECTIVE PROPERTIES OF TYPE 3 INACTIVATED POLIOVIRUS VACCINE Eugenia Dragunsky, Alexander Ivanov, Joan Enterline, Shinobu Abe, So Hashizume and Konstantin Chumakov.
P38 R 75761, A LEAD COMPOUND FOR THE DEVELOPMENT OF ANTIVIRAL DRUGS IN LATE STAGE POLIOMYELITIS ERADICATION STRATEGIES AND BEYOND B. Thys, A. M. De Palma, J. Neyts, K. Andries, R. Vrijsen and B. Rombaut.
P39 THE COMBINED USE OF ANTIVIRALS; A STRATEGY TO CONTAIN OUTBREAKS OF POLIOVIRUS IN THE END STAGES OF THE POLIOVIRUS ERADICATION H.J. Thibaut, A. De Palma, G. Pürstinger, E. Wimmer, A.K. Patick, K. Andries, B. Rombaut and J. Neyts.
P40 MULTIPLE INDEPENDENT EMERGENCES OF TYPE 2 VACCINE-DERIVED POLIOVIRUSES IN NORTHERN NIGERIA, 2005 Cara C. Burns, Jing Shaw, Soji Oderinde, David Bukbuk, Marycelin Baba, Festus Adu, Nicksy Gumede, A. J. Williams, Paul Chenoweth, Mark Pallansch, and Olen Kew.
P41 INCREASED SECRETION OF ANTIGENIC DIVERGENT VACCINE VIRUSES AFTER VACCINATION OF NEWBORNS WITH MONOVALENT ORAL POLIO VACCINE TYPE 1 Sabine van der Sanden,, Mark Pallansch, Jan van de Kassteele, Nasr El-Sayed, Roland W. Sutter, Marion Koopmans, and Harrie van der Avoort.
P42 STRUCTURAL CHANGES DURING HUMAN RHINOVIRUS UNCOATING Angela Pickl-Herk, Gerhard Bilek, Enrst Kenndler and Dieter Blaas.
P43 ENTRY OF DAF-BINDING AND NON-DAF BINDING COXSACKIEVIRUS INTO HELA CELLS K.P. Patel,, Carolyn B. Coyne and Jeffery M. Bergelson.
P44 COXSACKIEVIRUS B3 AND RECEPTOR INTERACTIONS Javier Cifuente, Valorie D. Bowman, Heather Holdaway, Carol Bator Kelly, Feng Lin, D. Edward Medof, Ricardo Gomez, and Susan Hafenstein.
P45 GENETIC AND PHYLOGENETIC ANALYSES OF THE VIRUS, 64-7855, ISOLATED FROM AMERICAN SOUTHERN RED-BACKED VOLE REVEALS A THIRD LJUNGAN VIRUS GENOTYPE C. Tolf, E. S. Johansson, R. B. Tesh, K. Edman and A. M. Lindberg.
P46 A HIGHLY DIVERGENT PICORNAVIRUS IN A MARINE MAMMAL A. Kapoor, J. Victoria, P. Simmonds, C. Wang, R.W. Shafer, R. Nims, O. Nielsen, E. Delwart.
P47 NEW GENOTYPING METHOD FOR HEPATITIS A VIRUS Andrea Normann and Bertram Flehmig.
P48 ANTIBODIES TO VIRUS GENOMES Yu.F. Drygin, M.N. Kirikova, A.V. Barskii, M.O. Gallyamov, A.S. Grokhovskaya, E.S. Gavryushina, T.S. Zatsepin, E.S. Nadezhdina Belozersky.
P49 RECOMBINATION OF POLIOVIRUSES – ADVANTAGE TO A RECOMBINANT STRAIN? Carita Savolainen-Kopra,, Merja Roivainen, Anna-Kaisa Hiekka, Elena Samoilovich, and Tapani Hovi.
P50 MOLECULAR EPIDEMIOLOGY OF FOOT-AND-MOUTH DISEASE VIRUS TYPE SAT 3 IN ZIMBABWE Julie M. Stirling and Nick J. Knowles.
P51 RECOMBINATION AMONG PICORNAVIRUSES IS RESPONSIBLE FOR THE MOSAIC STRUCTURE OF THEIR GENOMES Heath LE,, Jackson A.L, O'Neill H,, Maree F, Blignaut B, Carrillo C, Rodriguez L, Haydon DT and Martin DP.
P52 DEVELOPMENT OF A NEW DIAGNOSTIC TOOL FOR THE REAL TIME QUALITATIVE DETECTION OF ENTEROVIRUS RNA Bes Jérôme, Magro Stéphane, Grossiord Céline, Vignoles Matthieu, Raoux Nicolas, Barranger Côme and Joannes Martine Argene.
P53 MOLECULAR EPIDEMIOLOGY OF MENINGITIS-ASSOCIATED ENTEROVIRUS DETECTED IN SPAIN DURING EPIDEMIC YEAR 2006 M. Cabrerizo, J.E. Echevarria, I. González, A. Otero, T. de Miguel and G. Trallero.
P54 QUANTITATIVE REAL-TIME PCR CAN REPLACE ESTIMATION OF VIRUS TITERS BY TCID50 AND PFU ASSAYS N. Jonsson, M. Gullberg, K. Edman and A. M. Lindberg.